Paper34780705
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Goldstone SE and 18 others. Lancet Infect Dis, 2022. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial. Papers, record 34780705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34780705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
- PubMed
- Publication types
- Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anus Neoplasms | Major topic |
| Condylomata Acuminata | Major topic |
| Papillomavirus Infections | Major topic |
| Papillomavirus Vaccines | Major topic |
| Sexual and Gender Minorities | Major topic |
| Double-Blind Method | |
| Follow-Up Studies | |
| Homosexuality, Male | |
| Humans | |
| Immunogenicity, Vaccine | |
| Male | |
| Papillomaviridae |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00090285 | An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT07123558 | Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men | Background | ClinicalTrials.gov |
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42768360 | Elimination of HPV-associated cancers: universal HPV vaccination and the role of anal screening - a meeting report. | BMC Proc | 2026 | https://conductscience.org/library/papers/42768360 | PubMed |
| 42649891 | Anal High-Grade Squamous Intraepithelial Lesions in People Living with HIV: A Systematic Review of Treatment Outcomes. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649891 | PubMed |
| 42347661 | A Phase III, Randomized, Double-Blind, Active-Controlled Non-Inferiority Trial Evaluating the Immunogenicity and Safety of Gardisun, a Quadrivalent Human Papillomavirus Vaccine, Compared with Gardasil® in Healthy Volunteers Aged 15-35 Years. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347661 | PubMed |
| 42258368 | Willingness to Undergo Human Papillomavirus Testing Among Men Who Have Sex With Men in China Based on the Information-Motivation-Behavioral Skills Model: Online Cross-Sectional Study. | JMIR Public Health Surveill | 2026 | https://conductscience.org/library/papers/42258368 | PubMed |
| 42216453 | Strategies implemented to increase HPV vaccine uptake and confidence among men who have sex with men and transgender people: A systematic review. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42216453 | PubMed |
| 42183680 | Temporal Trends in Anal HPV Infection Among Men Who Have Sex With Men Attending Sexual Health Clinics in Three United States Cities, 2018-2024. | Sex Transm Dis | 2026 | https://conductscience.org/library/papers/42183680 | PubMed |
| 42179134 | Clinical research progress and challenges of vaccine for human papillomavirus-associated cancers. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42179134 | PubMed |
| 42155359 | Human Papillomavirus Vaccine Discourse and Sentiment on Reddit Before and After COVID-19: Mixed Methods Retrospective Cross-Sectional Study. | J Med Internet Res | 2026 | https://conductscience.org/library/papers/42155359 | PubMed |
| 42017894 | Estimating the age distribution of disease-causal HPV infection in women with high-grade cervical intraepithelial neoplasia in Denmark, Estonia, Norway, Slovenia, and Sweden: A modeling study. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42017894 | PubMed |
| 41866610 | Closing the Gap: HPV Vaccination and Head and Neck Cancer Prevention. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/41866610 | PubMed |
| 41783602 | High Risk of Incident-Persistent Human Papillomavirus Infection With 9-Valent Vaccine Types in Young Men With an HPV Infection. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/41783602 | PubMed |
| 41682921 | Dynamics of Cervical Lesions After Excisional Treatment in Relation to HPV Genotypes and Cytological Findings. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682921 | PubMed |
| 41658649 | Effect of Human Papillomavirus (HPV) Vaccine on Male Genital Disease: A Meta-Analysis of Randomised Controlled Trials. | Cureus | 2026 | https://conductscience.org/library/papers/41658649 | PubMed |
| 41653360 | SEOM-GEMCAD-TTD clinical guidelines for anal cancer (2025). | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41653360 | PubMed |
| 41607770 | Comprehensive evaluation of prophylactic HPV vaccines: a systematic review and meta-analysis of efficacy, safety, and immunogenicity in males and females. | Front Immunol | 2025 | https://conductscience.org/library/papers/41607770 | PubMed |
| 41586588 | Dynamics of anal HPV infection after 9vHPV vaccination in men who have sex with men (MSM) with HIV: A prospective, controlled cohort study. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41586588 | PubMed |
| 41276263 | Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/41276263 | PubMed |
| 41268414 | Incidence and persistent infection rates of type-specific HPV among HIV-infected males in China: a 5-year retrospective study. | Front Public Health | 2025 | https://conductscience.org/library/papers/41268414 | PubMed |
| 41013315 | High prevalence of bacterial STI, anal HPV, cytological abnormalities and anal lesions among MSM in Togo, 2021: a baseline analysis of the ANRS I MIE 12,400/DepIST-H cohort. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/41013315 | PubMed |
| 40910790 | The human papilloma virus (HPV) vaccination recommendations and funded programs for adults: A targeted literature review. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40910790 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34780705
GET https://conductscience.org/api/papers/v1/34780705/cited_by?page=2